The same table flags a history of acute pancreatitis, gallstones or biliary disease, chronic kidney disease with eGFR under 30, and type 1 diabetes or a ketosis history
Efficacy: Early data suggests it outperforms both other drugs, with some patients losing up to 24-30% of body weight in Phase 2 trials
This distinction matters because medication selection should reflect individual biomarker profiles and genetic predispositions, not a standardized approach
It is also noteworthy that MC1R activation might suppress the expression of COX-2 and cell adhesion molecules, suggesting a potential anti-inflammatory pathway through which MT-1 and similar compounds may exert further anti-fibrogenic action
Gastrointestinal side effects Many Ozempic users report nausea, bloating, and digestive discomfort, which can be distracting and mentally draining
The trade-off between tolerability and cardiovascular protection represents an important consideration for patient counseling and shared decision-making
![Henry Meds Semaglutide Review [2026]](https://innerbody.imgix.net/henry-semaglutide-with-ondansteron-close-up.jpg?auto=format,compress&fit=max&w=826&q=75)
